BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

945 related articles for article (PubMed ID: 20089000)

  • 21. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Galván AB; Mallo M; Arenillas L; Salido M; Espinet B; Pedro C; Florensa L; Serrano S; Solé F
    Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
    Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
    Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].
    Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia.
    Casas S; Aventín A; Fuentes F; Vallespí T; Granada I; Carrió A; Angel Martínez-Climent J; Solé F; Teixidó M; Bernués M; Duarte J; Maria Hernández J; Brunet S; Dolors Coll M; Sierra J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):16-25. PubMed ID: 15325089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of dual-color fluorescence in situ hybridization in acute myeloid leukemia with t (8; 21)].
    Li CW; Bo LJ; Dai Y; Liu XP; Qin S; Liu SH; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):32-5. PubMed ID: 16732938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping.
    Martínez-Ramírez A; Urioste M; Alvarez S; Vizmanos JL; Calasanz MJ; Cigudosa JC; Benítez J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):39-47. PubMed ID: 15325092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Submicroscopic deletions in 5q- associated malignancies.
    Crescenzi B; La Starza R; Romoli S; Beacci D; Matteucci C; Barba G; Aventin A; Marynen P; Ciolli S; Nozzoli C; Martelli MF; Mecucci C
    Haematologica; 2004 Mar; 89(3):281-5. PubMed ID: 15020265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
    Fröhling S; Kayser S; Mayer C; Miller S; Wieland C; Skelin S; Schlenk RF; Döhner H; Döhner K;
    Haematologica; 2005 Feb; 90(2):194-9. PubMed ID: 15710571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.
    Michalová K; Musilová J; Zemanová Z
    Czech Med; 1990; 13(4):133-44. PubMed ID: 2081440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isochromosome 5p and related anomalies: a novel recurrent chromosome abnormality in myeloid disorders.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Guéganic N; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Jul; 200(2):134-9. PubMed ID: 20620596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M-FISH applications in clinical genetics.
    Cetin Z; Berker Karaüzüm S; Yakut S; Mihçi E; Baumer A; Wey E; Taçoy S; Bağci G; Lüleci G
    Genet Couns; 2005; 16(3):257-68. PubMed ID: 16259323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study.
    Andersen MK; Christiansen DH; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2005 Apr; 42(4):358-71. PubMed ID: 15645489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
    Pitchford CW; Hettinga AC; Reichard KK
    Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
    Panani AD; Pappa V
    In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
    Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
    Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.